| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 1991 | 13-Cis Retinoic Acid Induces Cellular Differentiation and Durable Remission in Refractory Ki-1 Lymphoma | Chou, C. M.; Cheng, Ann-Lii; Su, I. J.; Wang, C. H.; Chou, C. M.; 鄭安理 | Cancer | | | |
| 1987 | Allogeneic Bone Marrow Transplantation in the Treatment of Leukemia--a Preliminary Report | CHEN, YAO-CHANG; WANG, CHIU-HWA; LIN, DONG-TSAMN ; CHENG, ANN-LII; LIU, TSANG-WU; TSAY, WOEI; TIEN, HWEI-FANG; LIU, MING-CHI; CHUU, WEN-MIN; LEE, LI-NA; SU, IH-JEN; HSIEH, RHONG-PHONG; SHEN, MING-CHING; 陳耀昌; 王秋華; 林東燦; 鄭安理; 劉滄梧; 蔡偉; 田蕙芬; 劉敏枝; 褚文銘; 李麗娜; 蘇益仁; 謝榮峰; 沈銘鏡 | 臺灣醫學會雜誌,v.86 | | | |
| 1994 | An Alternative Method to Overcome Central Venous Portable External Infusion Pump Blockage in Patients Receiving Weekly 24-Hour High-Dose Fluorouracil and Leucovorin | Cheng, Ann-Lii; Yeh, K. H.; 鄭安理 | Journal of Clinical Oncology | | | |
| 1997 | ANGIOIMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINEMIA--LACK OF A PROGNOSTIC VALUE OF CLEAR CELL MORPHOLOGY | CHANG, HUI-JU; SU, IH-JEN; CHEN, CHI-LONG; CHIANG, I-PING; CHEN, YAO-CHANG; WANG, CHIU-HWA; CHENG, ANN-LII | ONCOLOGY | | | |
| 2001 | Anti-Hilicobacter Pylori Therapy in the Treatment of Stage-Ie High Grade Malt Lymphoma of The | LIN, JAW-TOWN; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
| 2012 | AUY922, a heat shock protein 90 inhibitor, plus 5-fluorouracil inhibits tumors synergistically in gastric cancer MKN45 xenograft via down regulation of multiple pivotal growth factor receptors and oncoproteins | Yeh, Kun-Huei; Kao, Chiu-Hua; Fan, Hsun-Fang; Cheng, Chih-Jen; Lin, Yu-Lin; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
| 2015 | BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen | Chen, I-Chun; Gao, Ming; Hsiao, Lii-Ping; Huang, Yi-Wen; Yu, Huei-Chieh; Yeh, Ling-Chiun; Cheng, Ann-Lii; Lu, Yen-Shen | Cancer Res. | 0 | 0 | |
| 1985 | BOMES:A Promising Combination Chemotherapy in the Treatment of Central Nervous System Lymphoma | Cheng, Ann-Lii; Uen, W. C.; Tien, H. F.; Wang, C. H.; Chen, Yee-Chun; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
| 2012 | Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study | Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii | Hepatology | | |  |
| 1988 | Cancer and Cancer Treatment in Taiwan | Cheng, Ann-Lii; 鄭安理 | The 5th International Workshop on Cancer Treatment in Asian Countries | | | |
| 2008 | Carbonic Anhydrase Iii Promotes Transformation and Invasion Capability in Hepatoma Cells through Fak Signaling Pathway | HONG, CHIH-CHEN; LIANG, SAN-CHI; YAN, MING-DE; LAI, GI-MING; CHENG, ANN-LII; CHUANG, SHUANG-EN; 鄭安理 | Molecular Carcinogenesis | 37 | 35 | |
| 1989 | Characterization and Spectrum of Post-Thymic T Cell Malignancies in Taiwan | Su, I. J.; Cheng, Ann-Lii; Chen, Yee-Chun; Su, I. J.; Wang, C. H.; 鄭安理 | Cancer | | | |
| 1988 | Characterization of the spectrum of postthymic T-cell malignancies in Taiwan | Su, Ih-Jen; Wang, Chiu-Hwa; Cheng, Ann-Lii; Chen, Yao-Chang; Hsieh, Hong-Jong; Tien, Hwei-Fang; Tsai, Woei; Hu, Chung-Yi; Chen, Pei-Jer; Chen, Jen-Yang; Su, Hwei-Chi; Chuang, Sou-Ming; Shen, Ming-Ching; Kardin, Ma | Cancer,61() | | | |
| 1990 | Chemotherapy of Breast Cancer | CHENG, ANN-LII; CHEN, YAO-CHANG; 鄭安理; 陳耀昌 | 醫學繼續教育,v.2 | | | |
| 1993 | Chronic Oral VP-16 and Tamoxifen in the Treatment of Far-Advanced Hepatocellular Carcinoma | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
| 2015 | Clinical significance of LKB1 protein and gene expression in breast cancer. | Chen, I. Chun; Chang, Yuan-Ching; Lu, Yen-Shen; Huang, Chiun-Sheng; Kuo, Wen-Hung; Wang, Ming-Yang; Kuo, Kuan-Ting; Wu, Pei-Fang; Hsueh, Tsu-Hsin; Lin, Ching-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
| 2013 | Comparison of afatinib and erlotinib as radiosensitizing agents in bladder cancer cells | Tsai, Yu-Chieh; Tuan, Tsung-Fan; Ho, Pei-Yin; Liu, Wei-Lin; Chang, Liang-Yu; Pu, Yeong-Shiau; Cheng, Ann-Lii; Chen, Jason Chia-Hsien; 鄭安理; 成佳憲 | Cancer Res. | 0 | 0 | |
| 1992 | Cutaneous Angiocentric T Cell Lymphoma Associated with Epstein-Barr Virus | Cheng, Ann-Lii; Hsieh, H. C.; Tien, Hwei-Fang; Tsai, T. F.; Su, I. J.; Lu, Y. C.; 鄭安理 | Journal of American Academy Dermatology | | | |
| 1994 | Cutaneous Manifestations of Epstein-Barr Virus-Associated T-Cell Lymphoma | Cheng, Ann-Lii; Su, I. J.; Tsai, T. F.; 鄭安理 | Journal of American Academy Dermatology | | | |
| 1991 | Cutaneous Manifestations of Peripheral T-Cell Lymphoma | Su, I. J.; Hsieh, H. C.; Cheng, Ann-Lii; Su, I. J.; Hsieh, H. C.; 鄭安理 | Journal of American Academy Dermatology | | | |
